[1]
Bulu, A., Yalnız, M., Onalan, E. and Donder, E. 2022. The retrospective evaluation of response to adalimumab and infliximab treatment in patients diagnosed with inflammatory bowel disease. Medical Science and Discovery. 9, 8 (Aug. 2022), 438–445. DOI:https://doi.org/10.36472/msd.v9i8.783.